"10.1371_journal.pone.0102132","plos one","2014-07-09T00:00:00Z","Yoshikazu Suzuki; Mitsuru Iida; Iwao Miura; Toshiro Inubushi; Shigehiro Morikawa","Diagnostic Division, Otsuka Pharmaceutical Co., Ltd., Tokushima, Tokushima, Japan; Pharmaceutical Division, Otsuka Pharmaceutical Co., Ltd., Tokushima, Tokushima, Japan; Biomedical MR Science Research Center, Shiga University of Medical Science, Otsu, Shiga, Japan","Conceived and designed the experiments: YS MI IM. Performed the experiments: YS SM. Analyzed the data: YS SM. Contributed reagents/materials/analysis tools: YS SM TI. Wrote the paper: YS SM. Directed the study: TI MI.","YS, MI and IM are employees of Otsuka Pharmaceutical Co., Ltd. SM and TI have received donations for developing new magnetic resonance imaging technology from Otsuka Pharmaceutical Co., Ltd. YS and MI have stocks of Otsuka Pharmaceutical Co., Ltd. YS, MI and IM are registered as inventors of a related patent currently pending (WO 2007/132806). Patent application name: Magnetic resonance contrast medium using polyethylene glycol and magnetic resonance image pick-up method. International application number: PCT/JP2007/059849. International publication number: WO 2007/132806. The patent has been registered at this stage in Japan (Patent number: 5435940), Taiwan (Patent number: I400091) and Europe (Patent number: EP2020244B1). In addition to the patent information, the authors would like to describe related stockholding of authors in the competing interests section as follows. There are no further patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","07","Yoshikazu Suzuki","YS",5,TRUE,3,2,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
